PTC
SCMP

Petrus Trust Company’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Petrus Trust Company’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-31,481
Closed -$371K – 231
2017
Q3 		$371K Sell
31,481
-10,664
-25% -$120K 0.09% 72
2017
Q2 		$443K Hold
42,145
– – 0.1% 69
2017
Q1 		$464K Buy
42,145
+14,396
+52% +$167K 0.1% 63
2016
Q4 		$376K Buy
27,749
+2,322
+9% +$32.4K 0.09% 64
2016
Q3 		$313K Buy
25,427
+4,913
+24% +$57.9K 0.07% 82
2016
Q2 		$225K Buy
+20,514
New +$230K 0.05% 117
2015
Q2 		– Sell
-10,667
Closed -$166K – 110
2015
Q1 		$166K Sell
10,667
-738
-6% -$11.4K 0.04% 58
2014
Q4 		$163K Buy
+11,405
New +$120K 0.04% 55

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Petrus Trust Company's SCMP Position: Q4 2017 in Review

Petrus Trust Company sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 31,481 shares — an estimated $371K sold.

Petrus Trust Company first reported a position in SCMP in Q4 2014 and held it in 8 quarters. The position peaked at $464K in Q1 2017. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Petrus Trust Company reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Petrus Trust Company sold 31,481 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $371K.
  • Petrus Trust Company first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 8 quarters.
  • Petrus Trust Company's Sucampo Pharmaceuticals, Inc. position peaked at $464K in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Petrus Trust Company's 13F filing for Q4 2017, filed 14 Feb 2018.